191 related articles for article (PubMed ID: 34020568)
21. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections.
Chang YC; Huang YT; Hsu AY; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Lin JM; Chen WL; Tsai YY
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984630
[No Abstract] [Full Text] [Related]
22. Prognostic Factors for Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Dexamethasone Implant.
Lee H; Kang KE; Chung H; Kim HC
Korean J Ophthalmol; 2018 Apr; 32(2):116-125. PubMed ID: 29560616
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Intravitreal Dexamethasone Implant and Posterior Subtenon Triamcinolone Injection in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes.
Gumus G; Erdogan G; Gunay BO; Karatas Durusoy G
Ophthalmologica; 2022; 245(5):439-445. PubMed ID: 35921811
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema.
Castro-Navarro V; Cervera-Taulet E; Navarro-Palop C; Monferrer-Adsuara C; Hernández-Bel L; Montero-Hernández J
BMC Ophthalmol; 2019 Jan; 19(1):15. PubMed ID: 30634940
[TBL] [Abstract][Full Text] [Related]
25. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
[TBL] [Abstract][Full Text] [Related]
26. Early treatment with dexamethasone intravitreal implants in diabetic macular edema: Naïve versus refractory patients.
Bux AV; Fortunato F; Barone A; Russo V; Delle Noci N; Iaculli C
Eur J Ophthalmol; 2022 May; 32(3):1619-1626. PubMed ID: 34120496
[TBL] [Abstract][Full Text] [Related]
27. Optical coherence tomography and imaging biomarkers as outcome predictors in diabetic macular edema treated with dexamethasone implant.
Chou HD; Wu CH; Chiang WY; Chen NN; Hwang YS; Chen KJ; Lai CH; Wu PC; Chen YH; Yeung L; Shao SC; Lai CC; Wu WC
Sci Rep; 2022 Mar; 12(1):3872. PubMed ID: 35264625
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study.
Fallico M; Avitabile T; Castellino N; Longo A; Russo A; Bonfiglio V; Parisi F; Furino C; Panozzo G; Scorcia V; Carnevali A; Bandello F; Parodi MB; Cennamo G; Cillino S; Vadalà M; Sunseri Trapani V; Cagini C; Fiore T; Lupidi M; Parravano M; Varano M; Giorno P; Boscia F; Giancipoli E; Eandi C; Le Mer Y; Reibaldi M
Acta Ophthalmol; 2021 Feb; 99(1):e74-e80. PubMed ID: 32588978
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effect of ranibizumab and dexamethasone implant on serous retinal detachment in diabetic macular edema.
Demircan A; Ozkaya A; Alkin Z; Kemer B; Yesilkaya C; Demir G
J Fr Ophtalmol; 2018 Oct; 41(8):733-738. PubMed ID: 30213609
[TBL] [Abstract][Full Text] [Related]
30. VISUAL OUTCOMES IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH DEXAMETHASONE IMPLANT IN ROUTINE CLINICAL PRACTICE.
Urbančič M; Gardašević Topčić I; Matović K
Acta Clin Croat; 2021 Dec; 60(4):602-608. PubMed ID: 35734494
[TBL] [Abstract][Full Text] [Related]
31. Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant.
Iacono P; Parodi MB; Scaramuzzi M; Bandello F
Br J Ophthalmol; 2017 Jun; 101(6):791-795. PubMed ID: 27625164
[TBL] [Abstract][Full Text] [Related]
32. Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema.
Mahapatra SK; Kumari S
Indian J Ophthalmol; 2020 Mar; 68(3):490-493. PubMed ID: 32057010
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the effect of ranibizumab and dexamethasone implant in diabetic macular edema with concurrent epiretinal membrane.
Cakir A; Erden B; Bolukbasi S; Aydin A; Yurttaser Ocak S; Maden G; Elcioglu MN
J Fr Ophtalmol; 2019 Sep; 42(7):683-689. PubMed ID: 31088741
[TBL] [Abstract][Full Text] [Related]
34. HYPERREFLECTIVE FOCI AS AN INDEPENDENT VISUAL OUTCOME PREDICTOR IN MACULAR EDEMA DUE TO RETINAL VASCULAR DISEASES TREATED WITH INTRAVITREAL DEXAMETHASONE OR RANIBIZUMAB.
Chatziralli IP; Sergentanis TN; Sivaprasad S
Retina; 2016 Dec; 36(12):2319-2328. PubMed ID: 27258668
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Diabetic Macular Edema with Multiple Dexamethasone Intravitreal Implants: Evidence from Real-Life Experience.
De Geronimo D; Giorno P; Scarinci F; Boninfante A; Varano M; Parravano M
Ophthalmologica; 2020; 243(6):413-419. PubMed ID: 31760387
[TBL] [Abstract][Full Text] [Related]
36. Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant.
Zur D; Iglicki M; Sala-Puigdollers A; Chhablani J; Lupidi M; Fraser-Bell S; Mendes TS; Chaikitmongkol V; Cebeci Z; Dollberg D; Busch C; Invernizzi A; Habot-Wilner Z; Loewenstein A;
Acta Ophthalmol; 2020 Mar; 98(2):e217-e223. PubMed ID: 31421028
[TBL] [Abstract][Full Text] [Related]
37. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
38. Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials.
Danis RP; Sadda S; Li XY; Cui H; Hashad Y; Whitcup SM
Br J Ophthalmol; 2016 Jun; 100(6):796-801. PubMed ID: 26581718
[TBL] [Abstract][Full Text] [Related]
39. Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema.
Yoon CK; Sagong M; Shin JP; Lee SJ; Lee JE; Lee JE; Chung I; Jeong WJ; Pak KY; Kim HW
BMC Ophthalmol; 2021 Jan; 21(1):41. PubMed ID: 33451297
[TBL] [Abstract][Full Text] [Related]
40. Real-life outcomes of intravitreal ranibizumab, aflibercept, and dexamethasone implant administrations in patients with treatment-naïve diabetic macular edema.
Korkmaz A; Karti O; Zengin MO; Yuksel B; Kusbeci T
Saudi J Ophthalmol; 2022; 36(3):327-334. PubMed ID: 36276250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
